Visit COVID-19 resources

[Skip to Content]

Seeing through their eyes: lived experiences of people with retinitis pigmentosa – (Eye 31, 741 (May 2017))

May 11
2017

Seeing through their eyes: lived experiences of people with retinitis pigmentosa Eye 31, 741 (May 2017). doi:10.1038/eye.2016.315 Authors: M Prem Senthil, J Khadka & K Pesudovs

  • 11 May 2017

Long-term outcome of conjunctival fixation sutures to the sclera for prolapsed subconjunctival orbital fat – (Eye 31, 749 (May 2017))

May 11
2017

Long-term outcome of conjunctival fixation sutures to the sclera for prolapsed subconjunctival orbital fat Eye 31, 749 (May 2017). doi:10.1038/eye.2016.302 Authors: M K Yang, N Kim, H-K Choung & S I Khwarg

  • 11 May 2017

SPARCS and Pelli–Robson contrast sensitivity testing in normal controls and patients with cataract – (Eye 31, 753 (May 2017))

May 11
2017

SPARCS and Pelli–Robson contrast sensitivity testing in normal controls and patients with cataract Eye 31, 753 (May 2017). doi:10.1038/eye.2016.319 Authors: L Gupta, V Cvintal, R Delvadia, Y Sun, E Erdem, C Zangalli, L Lu, S S Wizov, J Richman, E Spaeth & G L Spaeth

  • 11 May 2017

The incidence and risk factors for the development of vitreomacular interface abnormality in diabetic macular edema treated with intravitreal injection of anti-VEGF – (Eye 31, 762 (May 2017))

May 11
2017

The incidence and risk factors for the development of vitreomacular interface abnormality in diabetic macular edema treated with intravitreal injection of anti-VEGF Eye 31, 762 (May 2017). doi:10.1038/eye.2016.317 Authors: C-K Chang, C-K Cheng & C-H Peng

  • 11 May 2017

Surveillance of sight loss due to delay in ophthalmic treatment or review: frequency, cause and outcome – (Eye 31, 771 (May 2017))

May 11
2017

Surveillance of sight loss due to delay in ophthalmic treatment or review: frequency, cause and outcome Eye 31, 771 (May 2017). doi:10.1038/eye.2017.1 Authors: B Foot & C MacEwen

  • 11 May 2017